Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Net Income 2009–2025
Cytokinetics, Incorporated annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cytokinetics, Incorporated net income for the quarter ending March 31, 2026 was -206.0 M, a 27.67% increase year-over-year.
- Cytokinetics, Incorporated net income for the twelve months ending March 31, 2026 was -808.0 M, a 42.01% increase year-over-year.
- Cytokinetics, Incorporated annual net income for 2025 was -785.0 M, a 33.15% increase from 2024.
- Cytokinetics, Incorporated annual net income for 2024 was -589.5 M, a 12.03% increase from 2023.
- Cytokinetics, Incorporated annual net income for 2023 was -526.2 M, a 35.30% increase from 2022.
- Cytokinetics, Incorporated annual net income for 2022 was -389.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytokinetics, Incorporated Net Income — FAQ
Cytokinetics, Incorporated (CYTK) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytokinetics, Incorporated's net income?
Cytokinetics, Incorporated (CYTK) reported net income of -$785M for fiscal 2025.
Where can I see CYTK's net income history?
The chart and table above show Cytokinetics, Incorporated's net income by year and by quarter, including the growth rate.